Compliance with Procalcitonin Algorithm Antibiotic Recommendations for Patients in Medical Intensive Care Unit

被引:7
作者
Ammar, Abdalla A. [1 ]
Lam, Simon W. [1 ]
Duggal, Abhijit [2 ]
Neuner, Elizabeth A. [1 ]
Bass, Stephanie N. [1 ]
Guzman, Jorge A. [2 ]
Wang, Xiao-Feng [3 ]
Han, Xiaozhen [3 ]
Bauer, Seth R. [1 ]
机构
[1] Cleveland Clin, Dept Pharm, 9500 Euclid Ave,Hb 105, Cleveland, OH 44195 USA
[2] Cleveland Clin, Resp Inst, Cleveland, OH 44106 USA
[3] Cleveland Clin, Dept Quantitat Hlth Sci, Cleveland, OH 44106 USA
来源
PHARMACOTHERAPY | 2017年 / 37卷 / 02期
关键词
procalcitonin; biologic markers; critical care; antibacterial agents; clinical protocols; guideline adherence; ANTIMICROBIAL THERAPY; SEPTIC PATIENTS; BACTERIAL-INFECTION; GUIDE DURATION; ORGAN FAILURE; SEPSIS; METAANALYSIS; PNEUMONIA; EXPOSURE;
D O I
10.1002/phar.1887
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Study ObjectivesTo describe compliance with antibiotic recommendations based on a previously published procalcitonin (PCT)-guided algorithm in clinical practice, to compare PCT algorithm compliance rates between PCT assays ordered in the antibiotic initiation setting (PCT concentration measured less than 24 hours after antibiotic initiation or before antibiotic initiation) with those in the antibiotic continuation setting (PCT concentration measured 24 hours or more after antibiotic initiation), and to evaluate patient- and PCT-related factors independently associated with algorithm compliance in patients in the medical intensive care unit (MICU). DesignSingle-center retrospective cohort study. SettingLarge MICU in a tertiary care academic medical center. PatientsA total of 527 adults admitted to the MICU unit over a 2-year period (November 1, 2011-October 31, 2013) who had a total of 957 PCT assays performed. PCT assays whose results were determined in the MICU were allocated retrospectively to either the initiation setting cohort or the continuation setting cohort based on timing of the PCT assay. Measurements and Main ResultsEach PCT assay was treated as a separate episode. Antibiotic regimens were compared between the 24-hour periods before and after the results of each PCT assay and evaluated against an algorithm to determine compliance. Clinical, laboratory, PCT-related, and microbiologic variables were assessed during the 24-hour period after the PCT assay results to determine their influence on PCT algorithm compliance. A larger proportion of PCT episodes occurred in the initiation setting (540 [56.4%]) than in the continuation setting (417 [43.5%]). Overall, compliance with PCT algorithm recommendations was low (48.5%) and not significantly different between the initiation setting and the continuation setting (49.1% vs 47.7%, p=0.678). No patient-related or PCT-related factors were independently associated with PCT algorithm compliance on multivariable logistic regression. ConclusionCompliance with PCT algorithm antibiotic recommendations in both the initiation and continuation settings was lower than that reported in published randomized studies. No factors were independently associated with PCT algorithm compliance. Institutions using PCT assays to guide antibiotic use should assess compliance with algorithm antibiotic recommendations. Inclusion of a formalized antimicrobial stewardship program along with a PCT-guided algorithm is highly recommended.
引用
收藏
页码:177 / 186
页数:10
相关论文
共 32 条
[1]   Procalcitonin to Guide Duration of Antimicrobial Therapy in Intensive Care Units: A Systematic Review [J].
Agarwal, Rajender ;
Schwartz, David N. .
CLINICAL INFECTIOUS DISEASES, 2011, 53 (04) :379-387
[2]  
Albrich WC, 2012, ARCH INTERN MED, V172, P715, DOI 10.1001/archinternmed.2012.770
[3]   Procalcitonin levels to guide antibiotic therapy in adults with non-microbiologically proven apparent severe sepsis: a randomised controlled trial [J].
Annane, Djillali ;
Maxime, Virginie ;
Faller, Jean Pierre ;
Mezher, Chaouki ;
Clec'h, Christophe ;
Martel, Patricia ;
Gonzales, Helene ;
Feissel, Marc ;
Cohen, Yves ;
Capellier, Gilles ;
Gharbi, Miloud ;
Nardi, Olivier .
BMJ OPEN, 2013, 3 (02)
[4]   Review of Rapid Diagnostic Tests Used by Antimicrobial Stewardship Programs [J].
Bauer, Karri A. ;
Perez, Katherine K. ;
Forrest, Graeme N. ;
Goff, Debra A. .
CLINICAL INFECTIOUS DISEASES, 2014, 59 :S134-S145
[5]  
bioMerieux Inc, 2010, VIDAS B R A H M S PC
[6]   Effect of Introducing Procalcitonin on Antimicrobial Therapy Duration in Patients With Sepsis and/or Pneumonia in the Intensive Care Unit [J].
Bishop, Bryan M. ;
Bon, John J. ;
Trienski, Tamara L. ;
Pasquale, Timothy R. ;
Martin, Bradley R. ;
File, Thomas M., Jr. .
ANNALS OF PHARMACOTHERAPY, 2014, 48 (05) :577-583
[7]   DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS [J].
BONE, RC ;
BALK, RA ;
CERRA, FB ;
DELLINGER, RP ;
FEIN, AM ;
KNAUS, WA ;
SCHEIN, RMH ;
SIBBALD, WJ .
CHEST, 1992, 101 (06) :1644-1655
[8]   Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial [J].
Bouadma, Lila ;
Luyt, Charles-Edouard ;
Tubach, Florence ;
Cracco, Christophe ;
Alvarez, Antonio ;
Schwebel, Carole ;
Schortgen, Frederique ;
Lasocki, Sigismond ;
Veber, Benoit ;
Dehoux, Monique ;
Bernard, Maguy ;
Pasquet, Blandine ;
Regnier, Bernard ;
Brun-Buisson, Christian ;
Chastre, Jean ;
Wolff, Michel .
LANCET, 2010, 375 (9713) :463-474
[9]   Survival After Shock Requiring High-Dose Vasopressor Therapy [J].
Brown, Samuel M. ;
Lanspa, Michael J. ;
Jones, Jason P. ;
Kuttler, Kathryn G. ;
Li, Yao ;
Carlson, Rick ;
Miller, Russell R., III ;
Hirshberg, Eliotte L. ;
Grissom, Colin K. ;
Morris, Alan H. .
CHEST, 2013, 143 (03) :664-671
[10]   Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial [J].
de Jong, Evelien ;
van Oers, Jos A. ;
Beishuizen, Albertus ;
Vos, Piet ;
Vermeijden, Wytze J. ;
Haas, Lenneke E. ;
Loef, Bert G. ;
Dormans, Tom ;
van Melsen, Gertrude C. ;
Kluiters, Yvette C. ;
Kemperman, Hans ;
van den Elsen, Maarten J. ;
Schouten, Jeroen A. ;
Streefkerk, Joern O. ;
Krabbe, Hans G. ;
Kieft, Hans ;
Kluge, Georg H. ;
van Dam, Veerle C. ;
van Pelt, Joost ;
Bormans, Laura ;
Otten, Martine Bokelman ;
Reidinga, Auke C. ;
Endeman, Henrik ;
Twisk, Jos W. ;
van de Garde, Ewoudt M. W. ;
de Smet, Anne Marie G. A. ;
Kesecioglu, Jozef ;
Girbes, Armand R. ;
Nijsten, Maarten W. ;
de lange, Dylan W. .
LANCET INFECTIOUS DISEASES, 2016, 16 (07) :819-827